1. Home
  2. WBX vs VNDA Comparison

WBX vs VNDA Comparison

Compare WBX & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wallbox N.V.

WBX

Wallbox N.V.

N/A

Current Price

$2.96

Market Cap

118.0M

ML Signal

N/A

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$7.13

Market Cap

289.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WBX
VNDA
Founded
2015
2002
Country
Spain
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
118.0M
289.0M
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
WBX
VNDA
Price
$2.96
$7.13
Analyst Decision
Buy
Strong Buy
Analyst Count
4
3
Target Price
$9.00
$14.00
AVG Volume (30 Days)
28.6K
1.3M
Earning Date
02-26-2026
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$174,593,453.00
$212,074,000.00
Revenue This Year
N/A
$12.01
Revenue Next Year
$33.37
$21.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.12
52 Week Low
$2.83
$3.81
52 Week High
$14.40
$7.05

Technical Indicators

Market Signals
Indicator
WBX
VNDA
Relative Strength Index (RSI) 37.19 70.49
Support Level $2.88 $6.15
Resistance Level $3.36 $7.05
Average True Range (ATR) 0.22 0.48
MACD 0.03 0.10
Stochastic Oscillator 23.19 95.89

Price Performance

Historical Comparison
WBX
VNDA

About WBX Wallbox N.V.

Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: